Universidad Pública de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe3O4 Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor

    Pharmaceuticals, Vol. 16, Núm. 7

  2. Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds

    Antioxidants, Vol. 12, Núm. 1

2022

  1. Unveiling a New Selenocyanate as a Multitarget Candidate with Anticancer, Antileishmanial and Antibacterial Potential

    Molecules, Vol. 27, Núm. 21

2021

  1. New amides and phosphoramidates containing selenium: Studies on their cytotoxicity and antioxidant activities in breast cancer

    Antioxidants, Vol. 10, Núm. 4

2019

  1. Synthesis and leishmanicidal activity of novel urea, thiourea, and selenourea derivatives of diselenides

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5

2014

  1. A dihydroselenoquinazoline inhibits S6 ribosomal protein signalling, induces apoptosis and inhibits autophagy in MCF-7 cells

    European Journal of Pharmaceutical Sciences, Vol. 63, pp. 87-95

2013

  1. Bisacylimidoselenocarbamates cause G2/M arrest associated with the modulation of cdk1 and chk2 in human breast cancer MCF-7 cells

    Current Medicinal Chemistry, Vol. 20, Núm. 12, pp. 1609-1619

2012

  1. Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: Synthesis and study of their potential cytotoxic activity in vitro

    European Journal of Medicinal Chemistry, Vol. 47, Núm. 1, pp. 283-298

2010

  1. Synthesis and in vitro anticancer activities of some selenadiazole derivatives

    Archiv der Pharmazie, Vol. 343, Núm. 11-12, pp. 680-691